EMEA-002444-PIP02-18

Key facts

Active substance
Equine immunoglobulin F(ab')2 fragments targeting Shiga toxin
Therapeutic area
Infectious diseases
Decision number
P/0304/2019
PIP number
EMEA-002444-PIP02-18
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Prevention of haemolytic uraemic syndrome
Route(s) of administration
Intravenous use
Contact for public enquiries
Chemo Research, S.L

Tel.: +34 913021500
E-mail: covadonga.paneda@exeltis.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating